Medicament intermediate and preparation method of fluroxypyr 1-methylheptyl ester
A fluroxypyr sec-octyl ester and intermediate technology, applied in the field of organic synthesis, can solve the problems of unfavorable industrial production, limited raw materials, difficult operation, etc., and achieve the effects of avoiding product loss, low cost, and reasonable route design
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0020] The embodiment of the present invention provides a kind of preparation method of pharmaceutical intermediate, it comprises:
[0021] In the presence of molecular sieves, the pentachloropyridine is successively reacted with a fluorination reagent and an amination reagent for fluorination and amination reactions by using a one-pot method to obtain a drug intermediate; wherein, the structural formula of the drug intermediate is
[0022] The drug intermediate has a wide range of applications and can be used to synthesize a variety of polychlorinated drug molecules, for example, fluroxypyr sec-octyl ester that can be used as a herbicide. In the prior art, a two-step method is usually adopted for the synthesis of the drug intermediate, that is, the fluorination reaction is first carried out to pentachloropyridine to obtain the intermediate dichlorotrifluoropyridine, and its structural formula is Then carry out amination reaction to dichlorotrifluoropyridine. Due to the co...
Embodiment 1
[0043] The present embodiment provides a kind of preparation method of pharmaceutical intermediate, and its reaction formula is
[0044]
[0045] Its preparation steps include:
[0046] S1. Weigh 500mmol of potassium fluoride in a reaction flask, dissolve it in 5000ml of N,N-dimethylacetamide, add 0.5mmol of benzyltriethylammonium chloride as a catalyst, and then add 100mmol of pentachloro Pyridine and 5 mmol of 4A molecular sieve were heated up to 120° C. for 3 h to obtain a solution containing dichlorotrifluoropyridine.
[0047] S2. Cool the above-mentioned solution containing dichlorotrifluoropyridine to 10°C, and slowly add 30wt% ammonia water dropwise at 10°C, and detect the reaction by TLC. After the reaction of dichlorotrifluoropyridine is complete, stop the reaction and separate to obtain White solid, the desired drug intermediate (yield 95.3%).
Embodiment 2
[0049] The present embodiment provides a kind of preparation method of pharmaceutical intermediate, and its reaction formula is
[0050]
[0051] Its preparation steps include:
[0052] S1. Weigh 1000mmol of sodium fluoride in a reaction flask, dissolve it in 5000ml of N,N-dimethylacetamide, add 5mmol of benzyltriethylammonium chloride as a catalyst, and then add 100mmol of pentachloropyridine and 50 mmol of 4A molecular sieves, heated to 150 ° C for 1 h to obtain a solution containing dichlorotrifluoropyridine.
[0053] S2. Cool the above-mentioned solution containing dichlorotrifluoropyridine to 0°C, and slowly feed ammonia gas into the solution at 0°C, and detect the reaction by TLC. After the reaction of dichlorotrifluoropyridine is complete, stop the reaction and separate A white solid, the desired drug intermediate, was obtained (yield: 92.7%).
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com